Tetraphase Pharmaceuticals Announces Closing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall St awaits Nvidia's AI verdict after hot inflation data
- Oil rises as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Citi sees an opportunity in Oracle after ’one of the most extreme’ stock drawdowns
- Boston Scientific discloses cybersecurity incident causing global disruption
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Tetraphase Pharma (TTPH) Closes 4.95M Common Offering for Proceeds of $173.1M
March 17, 2015 12:28 PM EDTTetraphase Pharma (NASDAQ: TTPH) announced the closing of its underwritten public offering of 4,945,000 shares of common stock at an offering price of $35.00 per share. The shares of common stock issued and sold in the offering at the closing include 645,000 shares issued upon... More
